메뉴 건너뛰기




Volumn 19, Issue 2, 2002, Pages 97-102

Natural coagulation inhibitors and inflammation

(1)  Mammen, Eberhard F a  

a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING INHIBITOR; CYTOKINE; D DIMER; FIBRINOGEN; HEPARIN; MOLECULAR MARKER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN C; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

EID: 0036401242     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (47)
  • 1
    • 0031975435 scopus 로고    scopus 로고
    • The haematological manifestations of sepsis
    • Mammen EF. The haematological manifestations of sepsis. J Antimicrobial Chemotherapy 1998;41(Suppl A):17-24.
    • (1998) J Antimicrobial Chemotherapy , vol.41 , Issue.SUPPL. A , pp. 17-24
    • Mammen, E.F.1
  • 2
    • 0034278977 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation
    • Mammen EF. Disseminated intravascular coagulation. Clin Lab Sci 2000;13:239-45.
    • (2000) Clin Lab Sci , vol.13 , pp. 239-245
    • Mammen, E.F.1
  • 3
    • 0035216914 scopus 로고    scopus 로고
    • Advances in the understanding of the pathogenic pathways of disseminated intravascular coagulation results in more insight in the clinical picture and better management strategies
    • Levit M, de Jong E, van der Poll T, ten Cate H. Advances in the understanding of the pathogenic pathways of disseminated intravascular coagulation results in more insight in the clinical picture and better management strategies. Semin Thromb Hemost 2001;27:569-76.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 569-576
    • Levit, M.1    De Jong, E.2    Van Der Poll, T.3    Ten Cate, H.4
  • 4
    • 0035216945 scopus 로고    scopus 로고
    • Laboratory testing in disseminated intravascular coagulation
    • Toh CH. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:653-6.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 653-656
    • Toh, C.H.1
  • 6
    • 0033584457 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation
    • Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
    • (1999) N Engl J Med , vol.341 , pp. 586-592
    • Levi, M.1    Ten Cate, H.2
  • 7
    • 0035217849 scopus 로고    scopus 로고
    • Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation
    • Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:657-66.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 657-666
    • Horan, J.T.1    Francis, C.W.2
  • 8
    • 0035216815 scopus 로고    scopus 로고
    • Fibrinolysis in disseminated intravascular coagulation
    • Hack CE. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:633-8.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 633-638
    • Hack, C.E.1
  • 9
    • 0032697618 scopus 로고    scopus 로고
    • Biochemistry and physiology of blood coagulation
    • Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999;82:165-74.
    • (1999) Thromb Haemost , vol.82 , pp. 165-174
    • Mann, K.G.1
  • 10
    • 18044385747 scopus 로고    scopus 로고
    • The tissue factor pathway in disseminated intravascular coagulation
    • Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:605-17.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 605-617
    • Osterud, B.1    Bjorklid, E.2
  • 11
    • 0016790233 scopus 로고
    • The endotoxin-induced coagulant activity of human monocytes
    • Rivers RP, Hathaway WE, Weston WI. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975;30:311-6.
    • (1975) Br J Haematol , vol.30 , pp. 311-316
    • Rivers, R.P.1    Hathaway, W.E.2    Weston, W.I.3
  • 12
    • 0035217872 scopus 로고    scopus 로고
    • Regulatory role of cytokines in disseminated intravascular coagulation
    • van der Poll T, de Jong E, Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:639-51.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 639-651
    • Van Der Poll, T.1    De Jong, E.2    Levi, M.3
  • 13
    • 0024991650 scopus 로고
    • Regulation of coagulation by a multivalent Kunitz-type inhibitor
    • Broze GJ Jr, Warren LA, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990;29:7539-44.
    • (1990) Biochemistry , vol.29 , pp. 7539-7544
    • Broze G.J., Jr.1    Warren, L.A.2    Novotny, W.F.3
  • 14
    • 0002425830 scopus 로고
    • Regulation of blood coagulation by protease inhibitors
    • In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds); Philadelphia: Saunders
    • Broze GJ Jr, Tollefsen DM. Regulation of blood coagulation by protease inhibitors. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds). The Molecular Basis of Blood Disorders. 2nd ed. Philadelphia: Saunders, 1994:629-56.
    • (1994) The Molecular Basis of Blood Disorders. 2nd ed , pp. 629-656
    • Broze G.J., Jr.1    Tollefsen, D.M.2
  • 15
    • 0029039574 scopus 로고
    • Tissue factor pathway inhibitor and the current concept of blood coagulation
    • Broze GJ Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis 1995;1:7-13.
    • (1995) Blood Coagul Fibrinolysis , vol.1 , pp. 7-13
    • Broze G.J., Jr.1
  • 16
    • 0031906776 scopus 로고    scopus 로고
    • Antithrombin: Its physiological importance and role in DIC
    • Mammen EF. Antithrombin: Its physiological importance and role in DIC. Semin Thromb Hemost 1998;24:19-25.
    • (1998) Semin Thromb Hemost , vol.24 , pp. 19-25
    • Mammen, E.F.1
  • 17
    • 0019163952 scopus 로고
    • The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin
    • Jordan RE, Oosta GM, Gardner WT, Rosenberg RD. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. J Biol Chem 1980;255:10081-96.
    • (1980) J Biol Chem , vol.255 , pp. 10081-10096
    • Jordan, R.E.1    Oosta, G.M.2    Gardner, W.T.3    Rosenberg, R.D.4
  • 18
    • 0029593690 scopus 로고
    • Clinical relevance of antithrombin deficiencies
    • Mammen EF. Clinical relevance of antithrombin deficiencies. Semin Hematol 1995;32(Suppl 2):2-6.
    • (1995) Semin Hematol , vol.32 , Issue.SUPPL. 2 , pp. 2-6
    • Mammen, E.F.1
  • 20
    • 0025807728 scopus 로고
    • DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock and organ damage
    • Taylor FB Jr, Chang ACK, Peer GT, et al. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock and organ damage. Blood 1991;78:364-8.
    • (1991) Blood , vol.78 , pp. 364-368
    • Taylor F.B., Jr.1    Chang, A.C.K.2    Peer, G.T.3
  • 21
    • 0024343069 scopus 로고
    • Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells
    • Yamanuchi T, Umeda F, Inoguchi I, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989;163:1404-11.
    • (1989) Biochem Biophys Res Commun , vol.163 , pp. 1404-1411
    • Yamanuchi, T.1    Umeda, F.2    Inoguchi, I.3    Nawata, H.4
  • 22
    • 0031930384 scopus 로고    scopus 로고
    • The antiinflammatory properties of antithrombin III: New therapeutic implications
    • Okajima K, Uchiba M. The antiinflammatory properties of antithrombin III: New therapeutic implications. Semin Thromb Hemost 1998;24:27-32.
    • (1998) Semin Thromb Hemost , vol.24 , pp. 27-32
    • Okajima, K.1    Uchiba, M.2
  • 23
    • 0029587161 scopus 로고
    • Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation
    • Jochum M. Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation. Semin Hematol 1995;32(Suppl 2):19-32.
    • (1995) Semin Hematol , vol.32 , Issue.SUPPL. 2 , pp. 19-32
    • Jochum, M.1
  • 24
    • 0033859376 scopus 로고    scopus 로고
    • Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway
    • Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Physiol (Cell Physiol) 2000;279:98-107.
    • (2000) Am J Physiol (Cell Physiol) , vol.279 , pp. 98-107
    • Hoffmann, J.N.1    Vollmar, B.2    Inthorn, D.3    Schildberg, F.W.4    Menger, M.D.5
  • 25
    • 0035293659 scopus 로고    scopus 로고
    • Antithrombin reduces mesenteric vascular leukocyte interactions and small intestine injury in endotoxemis rats
    • Neviere R, Tournoys A, Mordon S, et al. Antithrombin reduces mesenteric vascular leukocyte interactions and small intestine injury in endotoxemis rats. Shock 2001;15:220-5.
    • (2001) Shock , vol.15 , pp. 220-225
    • Neviere, R.1    Tournoys, A.2    Mordon, S.3
  • 26
    • 0029781690 scopus 로고    scopus 로고
    • Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin
    • Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin. Am J Physiol 1996; 270:921-30.
    • (1996) Am J Physiol , vol.270 , pp. 921-930
    • Uchiba, M.1    Okajima, K.2    Murakami, K.3    Okabe, H.4    Takatsuki, K.5
  • 27
    • 0031894499 scopus 로고    scopus 로고
    • Therapeutic use of antithrombin concentrates in sepsis
    • Mammen EF, Balk R, Emerson T Jr, et al. Therapeutic use of antithrombin concentrates in sepsis. Semin Thromb Hemost 1998;24:183-94.
    • (1998) Semin Thromb Hemost , vol.24 , pp. 183-194
    • Mammen, E.F.1    Balk, R.2    Emerson T., Jr.3
  • 28
    • 0031950793 scopus 로고    scopus 로고
    • Antithrombin III in animal models of sepsis and organ failure
    • Dickneite G. Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemost 1998;24:61-9.
    • (1998) Semin Thromb Hemost , vol.24 , pp. 61-69
    • Dickneite, G.1
  • 29
    • 0031881384 scopus 로고    scopus 로고
    • Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure
    • Eisele B, Lamy M. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Semin Thromb Hemost 1998;24:71-80.
    • (1998) Semin Thromb Hemost , vol.24 , pp. 71-80
    • Eisele, B.1    Lamy, M.2
  • 30
    • 0034868433 scopus 로고    scopus 로고
    • Recombinant antithrombin: Production and role in cardiovascular disorders
    • Levy JH, Weisinger A, Ziomek CA, Echelard Y. Recombinant antithrombin: Production and role in cardiovascular disorders. Semin Thromb Hemost 2001;27: 405-16.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 405-416
    • Levy, J.H.1    Weisinger, A.2    Ziomek, C.A.3    Echelard, Y.4
  • 31
    • 0031804584 scopus 로고    scopus 로고
    • Current drug treatment strategies for disseminated intravascular coagulation
    • de Jong E, Levi M, Stoutenbeek CP, van Deventer SJH. Current drug treatment strategies for disseminated intravascular coagulation. Drugs 1998;55: 767-77.
    • (1998) Drugs , vol.55 , pp. 767-777
    • De Jong, E.1    Levi, M.2    Stoutenbeek, C.P.3    Van Deventer, S.J.H.4
  • 32
    • 0035904368 scopus 로고    scopus 로고
    • High-dose antithrombin III in severe sepsis. A randomized controlled trial
    • Warren BL, Eid A, Singer P, et al. High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 2001;286:1869-78.
    • (2001) JAMA , vol.286 , pp. 1869-1878
    • Warren, B.L.1    Eid, A.2    Singer, P.3
  • 33
    • 84965393931 scopus 로고
    • Antithrombin III in shock and disseminated intravascular coagulation
    • Vinazzer HA. Antithrombin III in shock and disseminated intravascular coagulation. Clin Appl Thromb Hemost 1995;1:62-5.
    • (1995) Clin Appl Thromb Hemost , vol.1 , pp. 62-65
    • Vinazzer, H.A.1
  • 34
    • 0001976355 scopus 로고
    • The protein C anticoagulant system
    • In: Stamatoyannapoulos G, Nienhuis AW, Majerus PW, Varmus H (eds); Philadelphia: Saunders
    • Dahlbäck B, Stenflo J. The protein C anticoagulant system. In: Stamatoyannapoulos G, Nienhuis AW, Majerus PW, Varmus H (eds). The Molecular Basis of Blood Diseases. 2nd ed. Philadelphia: Saunders, 1994:599-628.
    • (1994) The Molecular Basis of Blood Diseases. 2nd ed , pp. 599-628
    • Dahlbäck, B.1    Stenflo, J.2
  • 35
    • 0002690104 scopus 로고    scopus 로고
    • Protein C, protein S, and thrombomodulin
    • In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds); Philadelphia. Lippincott Williams and Wilkins
    • Esmon CT. Protein C, protein S, and thrombomodulin. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed. Philadelphia. Lippincott Williams and Wilkins, 2001:335-54.
    • (2001) Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed , pp. 335-354
    • Esmon, C.T.1
  • 36
    • 0002695076 scopus 로고    scopus 로고
    • Hereditary and acquired thrombophilic syndromes
    • In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds); Philadelphia: Lippincott Williams and Wilkins
    • Marder VJ, Matei DA. Hereditary and acquired thrombophilic syndromes. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001:1243-75.
    • (2001) Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed , pp. 1243-1275
    • Marder, V.J.1    Matei, D.A.2
  • 37
    • 0026061609 scopus 로고
    • Protein C, protein S and C4b-binding protein in severe infection and septic shock
    • Hesselvik JF, Malm J, Dahlbäck B, et al. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991; 65:126-9.
    • (1991) Thromb Haemost , vol.65 , pp. 126-129
    • Hesselvik, J.F.1    Malm, J.2    Dahlbäck, B.3
  • 38
    • 0022601049 scopus 로고
    • Modulation of endothelial cell hemostasis properties by tumor necrosis factor
    • Nawroth PP, Stern DM. Modulation of endothelial cell hemostasis properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
    • (1986) J Exp Med , vol.163 , pp. 740-745
    • Nawroth, P.P.1    Stern, D.M.2
  • 39
    • 0027943163 scopus 로고
    • Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor
    • Fukudome K, Esmon CT. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994;269: 26486-91.
    • (1994) J Biol Chem , vol.269 , pp. 26486-26491
    • Fukudome, K.1    Esmon, C.T.2
  • 40
    • 0030034186 scopus 로고    scopus 로고
    • Activated protein C attenuates endotoxin induced pulmonary vascular injury by inhibiting activated leukocytes in rats
    • Murakami K, Okajima K, Uchiba M, et al. Activated protein C attenuates endotoxin induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996;87:642-7.
    • (1996) Blood , vol.87 , pp. 642-647
    • Murakami, K.1    Okajima, K.2    Uchiba, M.3
  • 41
    • 0023122016 scopus 로고
    • Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
    • Taylor FB Jr, Chang A, Esmon CT, et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987;70:918-25.
    • (1987) J Clin Invest , vol.70 , pp. 918-925
    • Taylor F.B., Jr.1    Chang, A.2    Esmon, C.T.3
  • 42
    • 0027993226 scopus 로고
    • Characteristic effects of activated protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits
    • Katsura Y, Aoki K, Tanabe H, et al. Characteristic effects of activated protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits. Thromb Res 1994;76:353-62.
    • (1994) Thromb Res , vol.76 , pp. 353-362
    • Katsura, Y.1    Aoki, K.2    Tanabe, H.3
  • 43
    • 0035826096 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant activated human protein C for severe sepsis
    • Bernhard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant activated human protein C for severe sepsis. N Engl J Med 2001;344: 699-709.
    • (2001) N Engl J Med , vol.344 , pp. 699-709
    • Bernhard, G.R.1    Vincent, J.L.2    Laterre, P.F.3
  • 44
    • 0033590515 scopus 로고    scopus 로고
    • Treating patients with severe sepsis
    • Wheeler AP, Bernhard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.
    • (1999) N Engl J Med , vol.340 , pp. 207-214
    • Wheeler, A.P.1    Bernhard, G.R.2
  • 45
    • 0029092928 scopus 로고
    • Sepsis trials, intersection of investigation, regulation, funding, and practice
    • Bernard GR. Sepsis trials, intersection of investigation, regulation, funding, and practice. Am J Resp Crit Care Med 1995;152:4-10.
    • (1995) Am J Resp Crit Care Med , vol.152 , pp. 4-10
    • Bernard, G.R.1
  • 46
    • 0026048714 scopus 로고
    • The pathogenesis of sepsis
    • Bone CR. The pathogenesis of sepsis. Ann Intern Med 1991;115:457-69.
    • (1991) Ann Intern Med , vol.115 , pp. 457-469
    • Bone, C.R.1
  • 47
    • 0035904322 scopus 로고    scopus 로고
    • Continuing challenges of sepsis research
    • Crowther MA, Marshall JC. Continuing challenges of sepsis research. JAMA 2001;286:1894-6.
    • (2001) JAMA , vol.286 , pp. 1894-1896
    • Crowther, M.A.1    Marshall, J.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.